Step-Ups in DNA Chip IPOs
This article was originally published in Start Up
Executive Summary
Companies focused on DNA chips have been perennial favorites of the IPO market, from Affymetrix Inc.'s $90 million IPO in April 1996 to Nanogen Inc.'s $64 million offering, Affymetrix, Hyseq Inc., Vysis Inc. and Nanogen Inc. all received pre-money valuations about 3-4 times the total amount paid in by private investors prior to IPO, and post-money multiples of about 4.5 to 5.5.